Answers are grounded in this paper and cite their sources.
Repair of osteoporotic bone defects is constrained not only by low bone mass but also by the convergence of disrupted systemic bone homeostasis and a dysfunctional local regenerative niche. Cellular senescence, diminished metabolic–epigenetic plasticity, defective inflammatory resolution, and impaired mechanosensing collectively compromise endogenous repair. Responsive hydrogels, catalytic nanomaterials, extracellular vesicle (EV)-based systems, three-dimensional and four-dimensional (3D/4D) manufacturing, and artificial intelligence (AI)-assisted screening provide complementary means to regulate local exposure and intercellular signaling, tune load transfer, and optimize material design. Yet efficacy is often inferred from short-term measures of osteogenic activity, mineralization, or bone mass, without adequate attention to disease-model fidelity, local exposure, material-specific causality, or durability. We propose an analytical framework that links dominant pathological constraints to the minimum material functions needed to address them and specifies the evidence required to support claims of functional recovery. The framework emphasizes material-specific causal attribution and the durability of endogenous repair beyond the period of exogenous support. Extending evaluation to progenitor function, vascular–osteogenic coupling, tissue mechanics, post-degradation load transfer, and long-term remodeling shifts assessment from osteogenic gain alone to the durability of tissue-level recovery during osteoporotic bone repair.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: